Page 17 - Device Exemption News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Business Wire. The AP news staff was not involved in its creation. U.S. IDE Trial Results for Glaukos’ iStent infinite™ Show Substantial Reduction in IOP January 13, 2021 GMT SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Jan 13, 2021-- Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that 12-month U.S. Investigational Device Exemption (IDE) pivotal trial data showed that its iStent infinite ™ Trabecular Micro...

Press release content from PR Newswire. The AP news staff was not involved in its creation. Interscope Announces FDA De Novo Marketing Authorization of the EndoRotor® System for Direct Endoscopic Necrosectomy (DEN) December 24, 2020 GMT NORTHBRIDGE, Mass., Dec. 24, 2020 /PRNewswire/ -- Interscope, Inc. announced today the receipt of FDA de novo clearance to market its EndoRotor® System in the United States for direct endoscopic necrosectomy (DEN), a minimally invasive treatment for walled-off pancreatic necrosis. The EndoRotor System received CE Mark in Europe for this indication in 2018. C...

Advanced Bifurcation Systems Holds First Closing of $11M Series A Financing Advanced Bifurcation Systems, Inc. (ABS), a Livermore, CA-based maker of the ABS System, a proprietary stent delivery system that is specifically designed to efficiently treat coronary bifurcation lesions, held the first closing of an $11m Series A equity financing.  The round was led by Cedars-Sinai, an internationally renowned academic medical center, and by a leading medical device manufacturer. Proceeds from the financing will be used to conduct in-human testing in accordance with the FDA PMA process, and ena...

Advanced Bifurcation Systems Announces First Closing of Series A Financing News provided by Share this article Share this article LIVERMORE, Calif., Dec. 16, 2020 /PRNewswire/ -- Advanced Bifurcation Systems, Inc. (ABS), a Livermore, CA-based maker of the ABS System, a proprietary stent delivery system that is specifically designed to efficiently treat coronary bifurcation lesions, is pleased to announce the first closing of an $11 million Series A equity financing.  The round was led by Cedars-Sinai, an internationally renowned academic medical center, and by a leading medical device manufa...

Published: Dec 16, 2020 By Joseph Constance A healthy immune system defends the body against disease and other conditions. However, if the immune system malfunctions, it can attack healthy cells, tissues and organs. Autoimmune disease impacts different parts of the body, weakening functionality. It may be life-threatening. Researchers are aware of more than 80 diseases that occur when the immune system attacks the body’s own organs, tissues and cells. The more common autoimmune diseases include type 1 diabetes, rheumatoid arthritis, systemic lupus erythematosus and inflammatory bowe...